BPCE
WST icon

Bank Pictet & Cie (Europe)’s West Pharmaceutical WST Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,070
Closed -$377K – 278
2023
Q4 		$377K Buy
1,070
+139
+15% +$49.2K 0.01% 211
2023
Q3 		$349K Buy
+931
New +$360K 0.01% 204

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s WST Position: Q1 2024 in Review

Bank Pictet & Cie (Europe) sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 1,070 shares — an estimated $377K sold.

Bank Pictet & Cie (Europe) first reported a position in WST in Q3 2023 and held it in 2 quarters. The position peaked at $377K in Q4 2023. 779 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Bank Pictet & Cie (Europe) reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 1,070 West Pharmaceutical shares in Q1 2024, an estimated $377K.
  • Bank Pictet & Cie (Europe) first reported a position in West Pharmaceutical in Q3 2023 and held it in 2 quarters.
  • Bank Pictet & Cie (Europe)'s West Pharmaceutical position peaked at $377K in Q4 2023.
  • 779 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2024, filed 7 May 2024.